vs
Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and CONSTELLIUM SE (CSTM). Click either name above to swap in a different company.
CONSTELLIUM SE is the larger business by last-quarter revenue ($2.2B vs $1.2B, roughly 1.8× Alignment Healthcare, Inc.). CONSTELLIUM SE runs the higher net margin — 5.1% vs 0.9%, a 4.2% gap on every dollar of revenue.
Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.
Constellium SE is an American-Swiss, French-based global manufacturer of aluminium rolled products, extruded products, and structural parts based on a large variety of advanced alloys. Constellium's C-TEC research center has been credited for advancing technology in the field of advanced aluminium alloy. Constellium primarily serves the aerospace, automotive, and packaging sectors. Large clients include Mercedes-Benz, Audi, BMW, Fiat Chrysler Automotive, Ford, Airbus, Boeing, and Bombardier.
ALHC vs CSTM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $2.2B |
| Net Profit | $11.4M | $112.0M |
| Gross Margin | — | — |
| Operating Margin | — | 7.5% |
| Net Margin | 0.9% | 5.1% |
| Revenue YoY | -74.7% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $0.79 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.0B | $2.2B | ||
| Q3 25 | $993.7M | $2.2B | ||
| Q2 25 | $1.0B | $2.1B | ||
| Q1 25 | $926.9M | $2.0B | ||
| Q4 24 | $701.2M | — | ||
| Q3 24 | $692.4M | — | ||
| Q2 24 | $681.3M | $1.9B |
| Q1 26 | $11.4M | — | ||
| Q4 25 | $-11.0M | $112.0M | ||
| Q3 25 | $3.7M | $88.0M | ||
| Q2 25 | $15.7M | $36.0M | ||
| Q1 25 | $-9.1M | $37.0M | ||
| Q4 24 | $-31.1M | — | ||
| Q3 24 | $-26.4M | — | ||
| Q2 24 | $-24.0M | $76.0M |
| Q1 26 | — | — | ||
| Q4 25 | -1.0% | 7.5% | ||
| Q3 25 | 0.8% | 5.8% | ||
| Q2 25 | 2.2% | 2.7% | ||
| Q1 25 | -0.6% | 3.1% | ||
| Q4 24 | -3.2% | — | ||
| Q3 24 | -2.8% | — | ||
| Q2 24 | -2.7% | 5.4% |
| Q1 26 | 0.9% | — | ||
| Q4 25 | -1.1% | 5.1% | ||
| Q3 25 | 0.4% | 4.1% | ||
| Q2 25 | 1.5% | 1.7% | ||
| Q1 25 | -1.0% | 1.9% | ||
| Q4 24 | -4.4% | — | ||
| Q3 24 | -3.8% | — | ||
| Q2 24 | -3.5% | 3.9% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.04 | $0.79 | ||
| Q3 25 | $0.02 | $0.62 | ||
| Q2 25 | $0.07 | $0.25 | ||
| Q1 25 | $-0.05 | $0.26 | ||
| Q4 24 | $-0.15 | — | ||
| Q3 24 | $-0.14 | — | ||
| Q2 24 | $-0.13 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $705.6M | $120.0M |
| Total DebtLower is stronger | — | $1.9B |
| Stockholders' EquityBook value | $206.9M | $952.0M |
| Total Assets | $1.3B | $5.4B |
| Debt / EquityLower = less leverage | — | 2.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $705.6M | — | ||
| Q4 25 | $604.2M | $120.0M | ||
| Q3 25 | $644.1M | $122.0M | ||
| Q2 25 | $503.8M | $133.0M | ||
| Q1 25 | $479.5M | $118.0M | ||
| Q4 24 | $470.6M | — | ||
| Q3 24 | $381.0M | — | ||
| Q2 24 | $363.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $323.2M | $1.9B | ||
| Q3 25 | $322.7M | $2.0B | ||
| Q2 25 | $322.3M | $2.0B | ||
| Q1 25 | $321.9M | $1.9B | ||
| Q4 24 | $321.4M | — | ||
| Q3 24 | $212.0M | — | ||
| Q2 24 | $211.7M | — |
| Q1 26 | $206.9M | — | ||
| Q4 25 | $179.3M | $952.0M | ||
| Q3 25 | $161.9M | $845.0M | ||
| Q2 25 | $141.0M | $780.0M | ||
| Q1 25 | $108.1M | $745.0M | ||
| Q4 24 | $99.9M | — | ||
| Q3 24 | $114.5M | — | ||
| Q2 24 | $123.7M | $796.0M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.1B | $5.4B | ||
| Q3 25 | $1.1B | $5.4B | ||
| Q2 25 | $1.0B | $5.4B | ||
| Q1 25 | $895.6M | $5.2B | ||
| Q4 24 | $782.1M | — | ||
| Q3 24 | $692.3M | — | ||
| Q2 24 | $716.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.80× | 2.00× | ||
| Q3 25 | 1.99× | 2.34× | ||
| Q2 25 | 2.29× | 2.53× | ||
| Q1 25 | 2.98× | 2.56× | ||
| Q4 24 | 3.22× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.71× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $128.7M | $218.0M |
| Free Cash FlowOCF − Capex | — | $109.0M |
| FCF MarginFCF / Revenue | — | 5.0% |
| Capex IntensityCapex / Revenue | — | 5.0% |
| Cash ConversionOCF / Net Profit | 11.27× | 1.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $159.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $128.7M | — | ||
| Q4 25 | $-50.4M | $218.0M | ||
| Q3 25 | $144.6M | $99.0M | ||
| Q2 25 | $29.1M | $114.0M | ||
| Q1 25 | $16.6M | $58.0M | ||
| Q4 24 | $-8.7M | — | ||
| Q3 24 | $26.2M | — | ||
| Q2 24 | $23.5M | $138.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-55.4M | $109.0M | ||
| Q3 25 | $139.1M | $24.0M | ||
| Q2 25 | $21.1M | $37.0M | ||
| Q1 25 | $8.4M | $-11.0M | ||
| Q4 24 | $-18.0M | — | ||
| Q3 24 | $16.9M | — | ||
| Q2 24 | $11.8M | $54.0M |
| Q1 26 | — | — | ||
| Q4 25 | -5.5% | 5.0% | ||
| Q3 25 | 14.0% | 1.1% | ||
| Q2 25 | 2.1% | 1.8% | ||
| Q1 25 | 0.9% | -0.6% | ||
| Q4 24 | -2.6% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 1.7% | 2.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 5.0% | ||
| Q3 25 | 0.6% | 3.5% | ||
| Q2 25 | 0.8% | 3.7% | ||
| Q1 25 | 0.9% | 3.5% | ||
| Q4 24 | 1.3% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 1.7% | 4.3% |
| Q1 26 | 11.27× | — | ||
| Q4 25 | — | 1.95× | ||
| Q3 25 | 38.77× | 1.13× | ||
| Q2 25 | 1.86× | 3.17× | ||
| Q1 25 | — | 1.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.82× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALHC
Segment breakdown not available.
CSTM
| Packaging Rolled Products | $1.0B | 46% |
| Automotive Rolled Products | $318.0M | 14% |
| Aerospace Rolled Products | $270.0M | 12% |
| Transportation Industry Defense And Other Rolled Products | $232.0M | 11% |
| Automotive Extruded Products | $220.0M | 10% |
| Other Extruded Products | $132.0M | 6% |
| Specialty And Other Thin Rolled Products | $22.0M | 1% |
